Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket

Gainers

• Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares surged 43.9% to $9.03 in pre-market trading after the company presented topline results from Phase 1 study of ACU193 for early Alzheimer's disease at the Alzheimer's Association International Conference 2023.
• PainReform Ltd. (NASDAQ:PRFX) shares gained 29.5% to $10.49 in pre-market trading. PainReform reported pricing of $1.5 million concurrent registered direct offering and private placement.
• Nova LifeStyle, Inc. (NASDAQ:NVFY) rose 27.7% to $2.81 in pre-market trading after declining over 6% on Friday.
• argenx SE (NASDAQ:ARGX) shares rose 24.3% to $471.47 in pre-market trading after reporting topline data from ADHERE study of VYVGART hytrulo in patients with chronic inflammatory demyelinating polyneuropathy.
• AERWINS Technologies Inc. (NASDAQ:AWIN) shares rose 23.3% to $0.6801 in pre-market trading.
• BridgeBio Pharma, Inc. (NASDAQ:BBIO) gained 20.5% to $21.98 in pre-market trading after the company's Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid cardiomyopathy met its primary endpoint.
• Nuvve Holding Corp. (NASDAQ:NVVE) rose 13.3% to $0.68 in pre-market trading after declining around 6% on Friday.
• Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) shares gained 13.2% to $1.46 in pre-market trading. Cadrenal Therapeutics reported closing of $7.5 million private placement priced at-the-market under Nasdaq rules.
• Edgio, Inc. (NASDAQ:EGIO) shares climbed 12.8% to $0.91 in pre-market trading.
• Genprex, Inc. (NASDAQ:GNPX) gained 10.3% to $0.9090 in pre-market trading. Genprex recently reported positive results from Phase 1 Acclaim-1 clinical trial.

Losers

• BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) fell 39.8% to $1.80 in pre-market trading after the company reported a proposed underwritten public offering.
• ViewRay, Inc. (NASDAQ:VRAY) fell 24.7% to $0.2739 in pre-market trading after the company filed voluntary Chapter 11 petitions.
• Ebix, Inc. (NASDAQ:EBIX) fell 21.6% to $19.40 in pre-market trading. Ebix, issued an informational release with a few clarifications and updates to the previously issued strategic update release on July 14, 2023.
• Frequency Therapeutics, Inc. (NASDAQ:FREQ) fell 16.5% to $0.5925 in pre-market trading. Frequency Therapeutics shares jumped 77% on Friday after the company agreed to merge with Korro Bio in an all- stock transaction.
• Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shares dropped 14.8% to $72.00 in pre-market trading.
• Minerva Surgical, Inc. (NASDAQ:UTRS) fell 14.3% to $0.26 in pre-market after jumping 23% on Friday. Minerva Surgical received a notice of allowance for its US patent application 17/569,850 titled "Tissue Extraction Devices And Methods."
• Baosheng Media Group Holdings Limited (NASDAQ:BAOS) shares fell 12.7% to $8.99 in pre-market trading after gaining more than 28% on Friday.
• Western Acquisition Ventures Corp. (NASDAQ:WAVS) shares fell 8.8% to $11.25 in pre-market trading after climbing over 18% on Friday.
• Monopar Therapeutics Inc. (NASDAQ:MNPR) fell 9.7% to $0.9034 in pre-market trading after jumping 17% on Friday.
• 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) fell 7.8% to $3.52 in pre-market trading after declining over 15% on Friday.

Now Read This: Market Volatility Declines; S&P 500 Settles Lower But Posts Weekly Gain